CSMED Stock Overview
CS MEDICA A/S develops, manufactures, and commercializes over the counter medical products containing cannabinoids for the treatment of psoriasis and arthritis.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
CS Medica A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr.6.79 |
| 52 Week High | kr.10.76 |
| 52 Week Low | kr.3.05 |
| Beta | -1.62 |
| 1 Month Change | -3.57% |
| 3 Month Change | -13.06% |
| 1 Year Change | -33.67% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -36.25% |
Recent News & Updates
Recent updates
Shareholder Returns
| CSMED | SE Pharmaceuticals | SE Market | |
|---|---|---|---|
| 7D | 14.0% | -5.7% | -1.6% |
| 1Y | -33.7% | 58.1% | 7.8% |
Return vs Industry: CSMED underperformed the Swedish Pharmaceuticals industry which returned 58.1% over the past year.
Return vs Market: CSMED underperformed the Swedish Market which returned 7.8% over the past year.
Price Volatility
| CSMED volatility | |
|---|---|
| CSMED Average Weekly Movement | 18.3% |
| Pharmaceuticals Industry Average Movement | 6.2% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in SE Market | 12.8% |
| 10% least volatile stocks in SE Market | 3.4% |
Stable Share Price: CSMED's share price has been volatile over the past 3 months.
Volatility Over Time: CSMED's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 9 | Lone Henriksen | www.cs-medica.com |
CS MEDICA A/S develops, manufactures, and commercializes over the counter medical products containing cannabinoids for the treatment of psoriasis and arthritis. It offers gels for psoriasis, arthritis, protective nasal, and wound healing; and CBD anti-hair loss serum, as well as sleep nasal sprays and pain patches. The company primarily offers its products under the CANNASEN brand name.
CS Medica A/S Fundamentals Summary
| CSMED fundamental statistics | |
|---|---|
| Market cap | kr.53.73m |
| Earnings (TTM) | -kr.14.51m |
| Revenue (TTM) | kr.1.07m |
78.4x
P/S Ratio-5.8x
P/E RatioIs CSMED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CSMED income statement (TTM) | |
|---|---|
| Revenue | kr.1.07m |
| Cost of Revenue | kr.153.73k |
| Gross Profit | kr.913.55k |
| Other Expenses | kr.15.43m |
| Earnings | -kr.14.51m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 24, 2024
| Earnings per share (EPS) | -1.18 |
| Gross Margin | 85.60% |
| Net Profit Margin | -1,359.80% |
| Debt/Equity Ratio | 84.3% |
How did CSMED perform over the long term?
See historical performance and comparison